Literature DB >> 18258857

c-kit is required for cardiomyocyte terminal differentiation.

Ming Li1, Nawazish Naqvi, Eiji Yahiro, Ke Liu, Pamela C Powell, Wayne E Bradley, David I K Martin, Robert M Graham, Louis J Dell'Italia, Ahsan Husain.   

Abstract

c-kit, the transmembrane tyrosine kinase receptor for stem cell factor, is required for melanocyte and mast cell development, hematopoiesis, and differentiation of spermatogonial stem cells. We show here that in the heart, c-kit is expressed not only by cardiac stem cells but also by cardiomyocytes, commencing immediately after birth and terminating a few days later, coincident with the onset of cardiomyocyte terminal differentiation. To examine the function of c-kit in cardiomyocyte terminal differentiation, we used compound heterozygous mice carrying the W (null) and W(v) (dominant negative) mutations of c-kit. In vivo, adult W/W(v) cardiomyocytes are phenotypically indistinguishable from their wild-type counterparts. After acute pressure overload adult W/W(v) cardiomyocytes reenter the cell cycle and proliferate, leading to left ventricular growth; furthermore in transgenic mice with cardiomyocyte-restricted overexpression of the dominant negative W(v) mutant, pressure overload causes cardiomyocytes to reenter the cell cycle. In contrast, in wild-type mice left ventricular growth after pressure overload results mainly from cardiomyocyte hypertrophy. Importantly, W/W(v) mice with pressure overload-induced cardiomyocyte hyperplasia had improved left ventricular function and survival. In W/W(v) mice, c-kit dysfunction also resulted in an approximately 14-fold decrease (P<0.01) in the number of c-kit(+)/GATA4(+) cardiac progenitors. These findings identify novel functions for c-kit: promotion of cardiac stem cell differentiation and regulation of cardiomyocyte terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258857      PMCID: PMC2763373          DOI: 10.1161/CIRCRESAHA.107.161737

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Aging and longevity: the IGF-1 enigma.

Authors:  Piero Anversa
Journal:  Circ Res       Date:  2005-09-02       Impact factor: 17.367

Review 2.  Asymmetric and symmetric stem-cell divisions in development and cancer.

Authors:  Sean J Morrison; Judith Kimble
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

Review 3.  Life and death of cardiac stem cells: a paradigm shift in cardiac biology.

Authors:  Piero Anversa; Jan Kajstura; Annarosa Leri; Roberto Bolli
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

4.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

Authors:  Shafie Fazel; Massimo Cimini; Liwen Chen; Shuhong Li; Denis Angoulvant; Paul Fedak; Subodh Verma; Richard D Weisel; Armand Keating; Ren-Ke Li
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 5.  Genetic dissection of cardiac growth control pathways.

Authors:  W R MacLellan; M D Schneider
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

6.  Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure.

Authors:  Richard K Cheng; Tomohiro Asai; Haiying Tang; Nurin H Dashoush; Rina J Kara; Kevin D Costa; Yoshifumi Naka; Ed X Wu; Debra J Wolgemuth; Hina W Chaudhry
Journal:  Circ Res       Date:  2007-05-10       Impact factor: 17.367

7.  Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury.

Authors:  Patrick C H Hsieh; Vincent F M Segers; Michael E Davis; Catherine MacGillivray; Joseph Gannon; Jeffery D Molkentin; Jeffrey Robbins; Richard T Lee
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

Review 8.  Cardiac regeneration: repopulating the heart.

Authors:  Michael Rubart; Loren J Field
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

9.  Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Yiming Huang; Adam B Stein; Greg Hunt; Sumit Tiwari; Jai Varma; Yan Gu; Sumanth D Prabhu; Jan Kajstura; Piero Anversa; Suzanne T Ildstad; Roberto Bolli
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

10.  Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.

Authors:  Bernhard Kühn; Federica del Monte; Roger J Hajjar; Yuh-Shin Chang; Djamel Lebeche; Shima Arab; Mark T Keating
Journal:  Nat Med       Date:  2007-07-15       Impact factor: 53.440

View more
  46 in total

1.  Adult cardiac-resident MSC-like stem cells with a proepicardial origin.

Authors:  James J H Chong; Vashe Chandrakanthan; Munira Xaymardan; Naisana S Asli; Joan Li; Ishtiaq Ahmed; Corey Heffernan; Mary K Menon; Christopher J Scarlett; Amirsalar Rashidianfar; Christine Biben; Hans Zoellner; Emily K Colvin; John E Pimanda; Andrew V Biankin; Bin Zhou; William T Pu; Owen W J Prall; Richard P Harvey
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

2.  Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells.

Authors:  João Ferreira-Martins; Barbara Ogórek; Donato Cappetta; Alex Matsuda; Sergio Signore; Domenico D'Amario; James Kostyla; Elisabeth Steadman; Noriko Ide-Iwata; Fumihiro Sanada; Grazia Iaffaldano; Sergio Ottolenghi; Toru Hosoda; Annarosa Leri; Jan Kajstura; Piero Anversa; Marcello Rota
Journal:  Circ Res       Date:  2012-01-24       Impact factor: 17.367

3.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

5.  Partially Digested Adult Cardiac Extracellular Matrix Promotes Cardiomyocyte Proliferation In Vitro.

Authors:  Corin Williams; Kelly Sullivan; Lauren D Black
Journal:  Adv Healthc Mater       Date:  2015-05-18       Impact factor: 9.933

Review 6.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.

Authors:  Eleonora Cianflone; Iolanda Aquila; Mariangela Scalise; Pina Marotta; Michele Torella; Bernardo Nadal-Ginard; Daniele Torella
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

Review 7.  Development, Proliferation, and Growth of the Mammalian Heart.

Authors:  Marie Günthel; Phil Barnett; Vincent M Christoffels
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

Review 8.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

9.  A proliferative burst during preadolescence establishes the final cardiomyocyte number.

Authors:  Nawazish Naqvi; Ming Li; John W Calvert; Thor Tejada; Jonathan P Lambert; Jianxin Wu; Scott H Kesteven; Sara R Holman; Torahiro Matsuda; Joshua D Lovelock; Wesley W Howard; Siiri E Iismaa; Andrea Y Chan; Brian H Crawford; Mary B Wagner; David I K Martin; David J Lefer; Robert M Graham; Ahsan Husain
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

10.  Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family.

Authors:  Enzo R Porrello; Ahmed I Mahmoud; Emma Simpson; Brett A Johnson; David Grinsfelder; Diana Canseco; Pradeep P Mammen; Beverly A Rothermel; Eric N Olson; Hesham A Sadek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.